Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Roth adds more 'SMID-cap' names to second half top picks » 10:58
07/12/21
07/12
10:58
07/12/21
10:58
CLSD

Clearside Biomedical

$5.42 /

-0.09 (-1.63%)

, DARE

Dare Bioscience

$1.77 /

-0.085 (-4.58%)

, LIFE

aTyr Pharma

$4.66 /

-0.1 (-2.10%)

, ARVN

Arvinas

$81.99 /

-0.48 (-0.58%)

, HARP

Harpoon Therapeutics

$13.47 /

-0.04 (-0.30%)

, RAPT

Rapt Therapeutics

$33.55 /

-0.22 (-0.65%)

Roth Capital analyst…

Roth Capital analyst Zegbeh Jallah added more names to her second half of 2021 top picks. In addition to microcaps Clearside Biomedical (CLSD), Dare Bioscience (DARE) and aTyr Pharma (LIFE), the analyst added more "SMID-cap" names Arvinas (ARVN), Harpoon Therapeutics (HARP) and Rapt Therapeutics (RAPT) to her second half of 2021 top picks. Assuming limited setbacks from the Covid-19 delta variant, investors should see some important clinical catalysts, Jallah tells investors in a research note. As it relates to the healthcare sector, the analyst remains bullish despite the sector pullback.

ShowHide Related Items >><<
RAPT Rapt Therapeutics
$33.55 /

-0.22 (-0.65%)

LIFE aTyr Pharma
$4.66 /

-0.1 (-2.10%)

HARP Harpoon Therapeutics
$13.47 /

-0.04 (-0.30%)

DARE Dare Bioscience
$1.77 /

-0.085 (-4.58%)

CLSD Clearside Biomedical
$5.42 /

-0.09 (-1.63%)

ARVN Arvinas
$81.99 /

-0.48 (-0.58%)

CLSD Clearside Biomedical
$5.42 /

-0.09 (-1.63%)

06/18/21 Roth Capital
Clearside Biomedical price target raised to $15 from $9 at Roth Capital
06/17/21 Wedbush
Clearside Biomedical price target raised to $18 from $6 at Wedbush
06/15/21 Roth Capital
Clearside reported 'impressive' data in wet AMD, says Roth Capital
06/02/21 Roth Capital
Clearside success with Xipere can derisk pipeline, says Roth Capital
DARE Dare Bioscience
$1.77 /

-0.085 (-4.58%)

07/12/21 Roth Capital
Dare Bioscience NIH agreement should offset costs, says Roth Capital
07/07/21 Roth Capital
Dare Bioscience grant reflects large market need, says Roth Capital
06/30/21 Roth Capital
Roth Capital ups Dare target to $11, says PK data for DARE-HRT1 validates tech
03/31/21 Roth Capital
Dare Bioscience reaffirmed as top 2021 pick at Roth Capital
LIFE aTyr Pharma
$4.66 /

-0.1 (-2.10%)

05/18/21 JonesTrading
aTyr Pharma initiated with a Buy at JonesTrading
05/10/21 Laidlaw
aTyr Pharma initiated with a Buy at Laidlaw
03/16/21 Roth Capital
aTyr Pharma price target raised to $20 from $15 at Roth Capital
01/28/21 Roth Capital
Roth Capital says aTyr Pharma work on NRP2 'not to be ignored'
ARVN Arvinas
$81.99 /

-0.48 (-0.58%)

05/20/21 UBS
Arvinas initiated with a Buy at UBS
04/21/21 Truist
Truist starts Arvinas with a Buy on PROTACs potential
04/21/21 Truist
Arvinas initiated with a Buy at Truist
03/31/21 BMO Capital
Arvinas initiated with an Outperform at BMO Capital
HARP Harpoon Therapeutics
$13.47 /

-0.04 (-0.30%)

06/08/21
Fly Intel: Top five analyst downgrades
06/08/21 Citi
Harpoon Therapeutics downgraded to Neutral from Buy at Citi
06/07/21 Roth Capital
Harpoon prostate cancer data 'very encouraging,' says Roth Capital
06/07/21 Wedbush
Harpoon Therapeutics downgraded to Neutral at Wedbush
RAPT Rapt Therapeutics
$33.55 /

-0.22 (-0.65%)

06/23/21 JMP Securities
JMP raises Evelo Biosciences price target to $38 after Rapt reports data
06/23/21 H.C. Wainwright
Rapt Therapeutics price target raised to $56 from $29 at H.C. Wainwright
06/20/21 Piper Sandler
Rapt Therapeutics initiated with an Overweight at Piper Sandler
06/14/21 Wells Fargo
Rapt Therapeutics price target raised to $65 from $30 at Wells Fargo
RAPT Rapt Therapeutics
$33.55 /

-0.22 (-0.65%)

LIFE aTyr Pharma
$4.66 /

-0.1 (-2.10%)

HARP Harpoon Therapeutics
$13.47 /

-0.04 (-0.30%)

DARE Dare Bioscience
$1.77 /

-0.085 (-4.58%)

CLSD Clearside Biomedical
$5.42 /

-0.09 (-1.63%)

ARVN Arvinas
$81.99 /

-0.48 (-0.58%)

  • 16
    Jun
  • 07
    Jan
  • 16
    Dec
LIFE aTyr Pharma
$4.66 /

-0.1 (-2.10%)

RAPT Rapt Therapeutics
$33.55 /

-0.22 (-0.65%)

DARE Dare Bioscience
$1.77 /

-0.085 (-4.58%)

CLSD Clearside Biomedical
$5.42 /

-0.09 (-1.63%)

RAPT Rapt Therapeutics
$33.55 /

-0.22 (-0.65%)

LIFE aTyr Pharma
$4.66 /

-0.1 (-2.10%)

Recommendations
JMP raises Evelo Biosciences price target to $38 after Rapt reports data » 13:32
06/23/21
06/23
13:32
06/23/21
13:32
EVLO

Evelo Biosciences

$16.08 /

-0.07 (-0.43%)

, RAPT

Rapt Therapeutics

$34.45 /

-0.29 (-0.83%)

JMP Securities analyst…

JMP Securities analyst Gobind Singh raised the firm's price target on Evelo Biosciences (EVLO) to $38 from $36 and keeps an Outperform rating on the shares after adjusting his atopic dermatitis model assumptions based on the fireside chat with CEO Simba Gill at the firm's Life Sciences Conference. Rapt Therapeutics (RAPT) announced positive topline results from its Phase 1b trial of RPT193 plus topical ointment as monotherapy in patients with moderate-to-severe atopic dermatitis that support previously presented results on Evelo's oral EDP1815, said Singh, who would be a buyer of Evelo at current levels and thinks Rapt investors "should be as well."

ShowHide Related Items >><<
RAPT Rapt Therapeutics
$34.45 /

-0.29 (-0.83%)

EVLO Evelo Biosciences
$16.08 /

-0.07 (-0.43%)

EVLO Evelo Biosciences
$16.08 /

-0.07 (-0.43%)

06/23/21 Cantor Fitzgerald
Evelo Biosciences initiated with an Overweight at Cantor Fitzgerald
06/23/21 Cantor Fitzgerald
Evelo Biosciences initiated with an Overweight at Cantor Fitzgerald
04/12/21 Jefferies
Jefferies upgrades Evelo Biosciences to Buy on increased microbiome momentum
04/12/21 Jefferies
Evelo Biosciences upgraded to Buy from Hold at Jefferies
RAPT Rapt Therapeutics
$34.45 /

-0.29 (-0.83%)

06/23/21 H.C. Wainwright
Rapt Therapeutics price target raised to $56 from $29 at H.C. Wainwright
06/20/21 Piper Sandler
Rapt Therapeutics initiated with an Overweight at Piper Sandler
06/14/21 Wells Fargo
Rapt Therapeutics price target raised to $65 from $30 at Wells Fargo
06/14/21 Roth Capital
Rapt Therapeutics price target raised to $72 from $38 at Roth Capital
RAPT Rapt Therapeutics
$34.45 /

-0.29 (-0.83%)

EVLO Evelo Biosciences
$16.08 /

-0.07 (-0.43%)

  • 16
    Jun
  • 29
    Jan
  • 25
    Jun
RAPT Rapt Therapeutics
$34.45 /

-0.29 (-0.83%)

RAPT Rapt Therapeutics
$34.45 /

-0.29 (-0.83%)

EVLO Evelo Biosciences
$16.08 /

-0.07 (-0.43%)

Recommendations
Rapt Therapeutics price target raised to $56 from $29 at H.C. Wainwright » 06:31
06/23/21
06/23
06:31
06/23/21
06:31
RAPT

Rapt Therapeutics

$34.72 /

-0.68 (-1.92%)

H.C. Wainwright analyst…

H.C. Wainwright analyst Raghuram Selvaraju raised the firm's price target on Rapt Therapeutics to $56 from $29 and reiterates a Buy rating on the shares citing the positive Phase 1b data for RPT193 in atopic dermatitis. The analyst increased his probability of RPT193 approval to 50% from s 35%.

ShowHide Related Items >><<
RAPT Rapt Therapeutics
$34.72 /

-0.68 (-1.92%)

RAPT Rapt Therapeutics
$34.72 /

-0.68 (-1.92%)

06/20/21 Piper Sandler
Rapt Therapeutics initiated with an Overweight at Piper Sandler
06/14/21 Wells Fargo
Rapt Therapeutics price target raised to $65 from $30 at Wells Fargo
06/14/21 Roth Capital
Rapt Therapeutics price target raised to $72 from $38 at Roth Capital
06/14/21 Cantor Fitzgerald
Cantor ups Rapt target to $71 after 'robust' atopic dermatitis data
RAPT Rapt Therapeutics
$34.72 /

-0.68 (-1.92%)

  • 16
    Jun
RAPT Rapt Therapeutics
$34.72 /

-0.68 (-1.92%)

RAPT Rapt Therapeutics
$34.72 /

-0.68 (-1.92%)

Over a month ago
Initiation
Rapt Therapeutics initiated with an Overweight at Piper Sandler » 19:59
06/20/21
06/20
19:59
06/20/21
19:59
RAPT

Rapt Therapeutics

$34.45 /

+0.925 (+2.76%)

Piper Sandler analyst…

Piper Sandler analyst Edward Tenthoff initiated coverage of Rapt Therapeutics with an Overweight rating and $61 price target. The analyst notes Rapt reported positive Phase Ib data on RPT193 in atopic dermatitis showing a 36.3% EASI improvement versus 17.0% on placebo at week 4. The company will initiate a 16-week Phase IIb trial in 240 AD patients and a Phase IIa study in asthma next year, Tenthoff adds. The analyst also highlights that last November, Rapt also reported preliminary Phase II data showing 100mg QD FLX475 achieved early ORR of 50% in EBV+ lymphoma, 60% in CPI-naive nasopharyngeal cancer and 19% in CPI-naive head and neck cancer. The company will report additional Phase II data in the second half of 2021. He estimates Rapt now has pro forma cash of $233M.

ShowHide Related Items >><<
RAPT Rapt Therapeutics
$34.45 /

+0.925 (+2.76%)

RAPT Rapt Therapeutics
$34.45 /

+0.925 (+2.76%)

06/14/21 Wells Fargo
Rapt Therapeutics price target raised to $65 from $30 at Wells Fargo
06/14/21 Roth Capital
Rapt Therapeutics price target raised to $72 from $38 at Roth Capital
06/14/21 Cantor Fitzgerald
Cantor ups Rapt target to $71 after 'robust' atopic dermatitis data
06/14/21 Cantor Fitzgerald
Rapt Therapeutics price target raised to $71 from $51 at Cantor Fitzgerald
RAPT Rapt Therapeutics
$34.45 /

+0.925 (+2.76%)

  • 16
    Jun
RAPT Rapt Therapeutics
$34.45 /

+0.925 (+2.76%)

RAPT Rapt Therapeutics
$34.45 /

+0.925 (+2.76%)

On The Fly
Wall Street in Fives - Must Read Lists at Midday » 12:09
06/16/21
06/16
12:09
06/16/21
12:09
GM

General Motors

$62.21 /

+1.4 (+2.30%)

, F

Ford

$15.08 /

+0.08 (+0.53%)

, ELAN

Elanco

$35.95 /

+1.12 (+3.22%)

, KIN

Kindred Biosciences

$9.20 /

+2.85 (+44.88%)

, AMZN

Amazon.com

$3,398.69 /

+16.67 (+0.49%)

, APO

Apollo Global

$58.54 /

+0.54 (+0.93%)

, RBLX

Roblox

$84.38 /

-5.38 (-5.99%)

, VIAV

Viavi

$17.98 /

+0.52 (+2.98%)

, EXFO

Exfo

$6.92 /

+0.985 (+16.60%)

, KO

Coca-Cola

$55.02 /

-0.405 (-0.73%)

, WKHS

Workhorse Group

$15.43 /

+1.265 (+8.93%)

, OSK

Oshkosh

$126.18 /

-1.16 (-0.91%)

, CVS

CVS Health

$85.85 /

+0.44 (+0.52%)

, KKR

KKR

$56.49 /

+0.8 (+1.44%)

, LUV

Southwest

$57.46 /

+0.33 (+0.58%)

, RUN

Sunrun

$48.51 /

+5.34 (+12.37%)

, MNKD

MannKind

$4.41 /

+0.3 (+7.30%)

, UTHR

United Therapeutics

$184.32 /

+5.52 (+3.09%)

, GOED

1847 Goedeker

$3.34 /

+0.27 (+8.79%)

, TAL

TAL Education

$25.17 /

-3.68 (-12.76%)

, RAPT

Rapt Therapeutics

$32.84 /

-2.12 (-6.06%)

, ORCL

Oracle

$77.07 /

-4.57 (-5.60%)

, LZB

La-Z-Boy

$38.10 /

-4.25 (-10.04%)

, FRPT

Freshpet

$164.18 /

-0.92 (-0.56%)

, NUE

Nucor

$100.95 /

-0.96 (-0.94%)

, CNC

Centene

$74.10 /

+4.09 (+5.84%)

, DISH

Dish

$41.66 /

+1.5 (+3.74%)

, CCL

Carnival

$29.36 /

+0.745 (+2.60%)

, RCL

Royal Caribbean

$88.91 /

+2.03 (+2.34%)

, NCLH

Norwegian Cruise Line

$31.68 /

+0.83 (+2.69%)

, BNTX

BioNTech

$203.67 /

-14.31 (-6.56%)

, MAXR

Maxar Technologies

$41.55 /

+5.55 (+15.42%)

Get caught up quickly on…

ShowHide Related Items >><<
WKHS Workhorse Group
$15.43 /

+1.265 (+8.93%)

VIAV Viavi
$17.98 /

+0.52 (+2.98%)

UTHR United Therapeutics
$184.32 /

+5.52 (+3.09%)

TAL TAL Education
$25.17 /

-3.68 (-12.76%)

RUN Sunrun
$48.51 /

+5.34 (+12.37%)

RCL Royal Caribbean
$88.91 /

+2.03 (+2.34%)

RBLX Roblox
$84.38 /

-5.38 (-5.99%)

RAPT Rapt Therapeutics
$32.84 /

-2.12 (-6.06%)

OSK Oshkosh
$126.18 /

-1.16 (-0.91%)

ORCL Oracle
$77.07 /

-4.57 (-5.60%)

NUE Nucor
$100.95 /

-0.96 (-0.94%)

NCLH Norwegian Cruise Line
$31.68 /

+0.83 (+2.69%)

MNKD MannKind
$4.41 /

+0.3 (+7.30%)

MAXR Maxar Technologies
$41.55 /

+5.55 (+15.42%)

LZB La-Z-Boy
$38.10 /

-4.25 (-10.04%)

LUV Southwest
$57.46 /

+0.33 (+0.58%)

KO Coca-Cola
$55.02 /

-0.405 (-0.73%)

KKR KKR
$56.49 /

+0.8 (+1.44%)

GOED 1847 Goedeker
$3.34 /

+0.27 (+8.79%)

GM General Motors
$62.21 /

+1.4 (+2.30%)

FRPT Freshpet
$164.18 /

-0.92 (-0.56%)

F Ford
$15.08 /

+0.08 (+0.53%)

EXFO Exfo
$6.92 /

+0.985 (+16.60%)

ELAN Elanco
$35.95 /

+1.12 (+3.22%)

DISH Dish
$41.66 /

+1.5 (+3.74%)

CVS CVS Health
$85.85 /

+0.44 (+0.52%)

CNC Centene
$74.10 /

+4.09 (+5.84%)

CCL Carnival
$29.36 /

+0.745 (+2.60%)

BNTX BioNTech
$203.67 /

-14.31 (-6.56%)

APO Apollo Global
$58.54 /

+0.54 (+0.93%)

AMZN Amazon.com
$3,398.69 /

+16.67 (+0.49%)

GM General Motors
$62.21 /

+1.4 (+2.30%)

06/16/21 Citi
Citi sees path to over $100 per share for GM after guidance and EV spending hike
06/07/21 Barclays
General Motors price target raised to $70 from $66 at Barclays
06/04/21 JPMorgan
General Motors price target raised to $73 from $71 at JPMorgan
06/02/21 Morgan Stanley
Oil price rise 'significantly improves' EV payback math, says Morgan Stanley
F Ford
$15.08 /

+0.08 (+0.53%)

06/04/21 JPMorgan
Ford price target raised to $18 from $16 at JPMorgan
05/28/21 Deutsche Bank
Deutsche starts Lordstown with Hold on 'considerable uncertainty'
05/27/21
Fly Intel: Top five analyst upgrades
05/27/21 Jefferies
Ford 'playing to its strengths' with new EV strategy, says Jefferies
ELAN Elanco
$35.95 /

+1.12 (+3.22%)

06/15/21 Cleveland Research
Elanco upgraded to Neutral from Underperform at Cleveland Research
05/17/21 Citi
Elanco price target raised to $42 from $39 at Citi
05/11/21 Gabelli
Elanco upgraded to Buy from Hold at Gabelli
05/11/21 Barclays
Elanco upgraded to Equal Weight from Underweight at Barclays
KIN Kindred Biosciences
$9.20 /

+2.85 (+44.88%)

06/16/21 Aegis
Kindred Biosciences downgraded to Hold from Buy at Aegis
06/16/21 Aegis
Kindred Biosciences downgraded to Hold from Buy at Aegis
05/12/21 Alliance Global Partners
Kindred Biosciences price target raised to $15.25 from $9.25 at Alliance Global
12/24/20 Barclays
Kindred atopic dermatitis portfolio could net $130M in sales, says Barclays
AMZN Amazon.com
$3,398.69 /

+16.67 (+0.49%)

06/16/21 JPMorgan
JPMorgan values Amazon Prime at $1,000 per year, 8.5 times actual price
06/16/21 Jefferies
Jefferies adds Amazon.com to Franchise Picks list, removes Alphabet
06/16/21 Pivotal Research
Dish upgraded to Buy from Hold at Pivotal Research
06/15/21 JPMorgan
Amazon should surpass Walmart as largest retailer in 2022, says JPMorgan
APO Apollo Global
$58.54 /

+0.54 (+0.93%)

06/14/21 Citi
Athene Holding price target raised to $66 from $54 at Citi
05/14/21 Truist
Athene Holding price target raised to $68 from $56 at Truist
05/13/21 UBS
Athene Holding downgraded to Neutral from Buy at UBS
05/10/21 Citi
Citi boosts Apollo target to $72, opens 'Positive Catalyst Watch'
RBLX Roblox
$84.38 /

-5.38 (-5.99%)

06/16/21 Truist
Truist says May typically a down month for Roblox, June expected higher
06/16/21 Morgan Stanley
Morgan Stanley lowers Q2 estimates for Roblox, says long-term view unchanged
06/16/21 JPMorgan
Roblox shares likely range-bound after May metrics, says JPMorgan
06/16/21 Stifel
Roblox May KPIs 'probably not enough' to sustain shares' momentum, says Stifel
VIAV Viavi
$17.98 /

+0.52 (+2.98%)

02/03/21 B. Riley
Viavi price target raised to $20 from $19 at B. Riley Securities
02/01/21 B. Riley
Viavi price target raised to $19 from $18 at B. Riley Securities
01/26/21 MKM Partners
Viavi resumed with a Buy at MKM Partners
09/11/20 B. Riley
Viavi pullback a buying opportunity, says B. Riley FBR
EXFO Exfo
$6.92 /

+0.985 (+16.60%)

06/08/21 Canaccord
Exfo price target raised to $6 from $4 at Canaccord
06/08/21 Northland
Exfo price target raised to $7.25 from $6 at Northland
01/13/21 BMO Capital
Exfo price target raised to C$4 from C$3.75 at BMO Capital
07/09/20 B. Riley
EXFO results positive for Viavi and Dasan, says B. Riley FBR
KO Coca-Cola
$55.02 /

-0.405 (-0.73%)

06/15/21 Credit Suisse
Coca-Cola price target raised to $62 from $60 at Credit Suisse
06/04/21 Morgan Stanley
Coca-Cola price target raised to $64 from $60 at Morgan Stanley
05/14/21 Wells Fargo
Wells says Coca-Cola Energy discontinuation may 'rekindle' Monster M&A debate
05/14/21 Evercore ISI
Coke Energy discontinuation a 'small positive' for Monster, says Evercore ISI
WKHS Workhorse Group
$15.43 /

+1.265 (+8.93%)

06/08/21 Colliers
California HVIP vouchers 'an important development' for EV stocks, says Colliers
06/04/21
Fly Intel: Top five analyst downgrades
06/04/21 Cowen
Workhorse Group downgraded to Market Perform from Outperform at Cowen
05/11/21 B. Riley
B. Riley cuts Workhorse target but says earnings selloff overblown
OSK Oshkosh
$126.18 /

-1.16 (-0.91%)

06/04/21 Baird
DOD deal shows Oshkosh more active M&A strategy paying dividends, says Baird
05/12/21 Evercore ISI
Oshkosh price target raised to $166 from $133 at Evercore ISI
04/29/21 KeyBanc
Oshkosh price target raised to $140 from $133 at KeyBanc
04/29/21 Credit Suisse
Oshkosh price target raised to $154 from $138 at Credit Suisse
CVS CVS Health
$85.85 /

+0.44 (+0.52%)

05/27/21 Mizuho
CVS, Walgreens selloff on Amazon report overdone, says Mizuho
05/26/21 Deutsche Bank
Amazon unlikely to enter retail pharmacy business, says Deutsche Bank
05/19/21 BMO Capital
CVS Health price target raised to $96 from $90 at BMO Capital
05/19/21 Barclays
CVS Health price target raised to $100 from $92 at Barclays
KKR KKR
$56.49 /

+0.8 (+1.44%)

05/05/21 Credit Suisse
KKR price target raised to $66 from $60 at Credit Suisse
05/05/21 Deutsche Bank
KKR price target raised to $60 from $52 at Deutsche Bank
04/18/21 BMO Capital
OneMain Holdings downgraded to Market Perform from Outperform at BMO Capital
04/14/21 BMO Capital
KKR price target raised to $71 from $69 at BMO Capital
LUV Southwest
$57.46 /

+0.33 (+0.58%)

06/09/21 MKM Partners
Southwest initiated with a Buy at MKM Partners
04/15/21 Barclays
Southwest price target raised to $64 from $51 at Barclays
04/14/21
Fly Intel: Top five analyst upgrades
04/14/21 JPMorgan
Southwest upgraded to Neutral from Underweight at JPMorgan
RUN Sunrun
$48.51 /

+5.34 (+12.37%)

06/16/21 Morgan Stanley
Sunrun price target raised to $91 from $86 at Morgan Stanley
06/02/21 Guggenheim
Sunrun assumed with a Buy at Guggenheim
06/01/21 Roth Capital
Watering down of AB1139 positive for residential solar, says Roth Capital
05/07/21 Truist
Sunrun price target lowered to $81 from $95 at Truist
MNKD MannKind
$4.41 /

+0.3 (+7.30%)

05/13/21 RBC Capital
MannKind initiated with a Sector Perform at RBC Capital
02/26/21 H.C. Wainwright
MannKind price target raised to $6.50 from $2.50 at H.C. Wainwright
02/24/21 BTIG
MannKind price target raised to $8 from $4 at BTIG
12/29/20 BTIG
United Therapeutics' treprostinil development uses MannKind technology, say BTIG
UTHR United Therapeutics
$184.32 /

+5.52 (+3.09%)

05/06/21 H.C. Wainwright
United Therapeutics price target raised to $248 from $195 at H.C. Wainwright
04/26/21 Credit Suisse
United Therapeutics assumed with an Outperform at Credit Suisse
04/08/21 JPMorgan
United Therapeutics price target raised to $212 from $185 at JPMorgan
02/25/21 Wedbush
United Therapeutics price target raised to $260 from $255 at Wedbush
GOED 1847 Goedeker
$3.34 /

+0.27 (+8.79%)

TAL TAL Education
$25.17 /

-3.68 (-12.76%)

06/16/21 Morgan Stanley
TAL Education cut to Underweight on K9-related business risk at Morgan Stanley
06/16/21 Morgan Stanley
New Oriental Education downgraded on K9-related business risk at Morgan Stanley
06/16/21 Morgan Stanley
TAL Education downgraded to Underweight from Overweight at Morgan Stanley
06/11/21 Citi
Citi double downgrades Gaotu Techedu to Sell on Chinese regulation risk
RAPT Rapt Therapeutics
$32.84 /

-2.12 (-6.06%)

06/14/21 Wells Fargo
Rapt Therapeutics price target raised to $65 from $30 at Wells Fargo
06/14/21 Roth Capital
Rapt Therapeutics price target raised to $72 from $38 at Roth Capital
06/14/21 Cantor Fitzgerald
Cantor ups Rapt target to $71 after 'robust' atopic dermatitis data
06/14/21 Cantor Fitzgerald
Rapt Therapeutics price target raised to $71 from $51 at Cantor Fitzgerald
ORCL Oracle
$77.07 /

-4.57 (-5.60%)

06/16/21 Morgan Stanley
Oracle shares likely range-bound until visibility improves, says Morgan Stanley
06/16/21 Jefferies
Oracle price target raised to $80 from $75 at Jefferies
06/16/21 Monness Crespi
Monness Crespi would be buyers of Oracle on any post-earnings weakness
06/16/21 JPMorgan
Oracle price target raised to $77 from $73 at JPMorgan
LZB La-Z-Boy
$38.10 /

-4.25 (-10.04%)

11/19/20 Raymond James
La-Z-Boy price target raised to $46 from $37 at Raymond James
10/19/20 Sidoti
La-Z-Boy upgraded to Buy from Neutral at Sidoti
06/25/20 Stifel
La-Z-Boy price target raised to $37 from $25 at Stifel
FRPT Freshpet
$164.18 /

-0.92 (-0.56%)

06/14/21 Baird
Freshpet recall not symptomatic of systemic issue, says Baird
06/09/21 Jefferies
Chewy addition unlocks significant opportunity for Freshpet, says Jefferies
06/09/21 Oppenheimer
Oppenheimer views Freshpet partnership with Chewy 'very favorably'
05/25/21 Baird
Baird finds sign that Freshpet launch on Chewy.com looks 'imminent'
NUE Nucor
$100.95 /

-0.96 (-0.94%)

06/16/21 JPMorgan
Nucor initiated with a Neutral at JPMorgan
06/10/21 GLJ Research
GLJ ups U.S. Steel target, says valuation 'materially below reality'
05/14/21 BMO Capital
Nucor price target raised to $110 from $86 at BMO Capital
04/20/21
Fly Intel: Top five analyst upgrades
CNC Centene
$74.10 /

+4.09 (+5.84%)

06/08/21 BofA
Centene price target raised to $85 from $75 at BofA
05/18/21 Wells Fargo
Centene initiated with an Overweight at Wells Fargo
05/11/21 BMO Capital
Centene price target raised to $88 from $77 at BMO Capital
05/11/21 Stephens
Centene upgraded to Overweight following underperformance at Stephens
DISH Dish
$41.66 /

+1.5 (+3.74%)

06/16/21
Fly Intel: Top five analyst upgrades
06/09/21
Fly Intel: Top five analyst downgrades
06/09/21 JPMorgan
JPMorgan downgrades Dish to sell on wireless execution concerns
CCL Carnival
$29.36 /

+0.745 (+2.60%)

06/16/21 Wolfe Research
Wolfe upgrades 'Big 3' cruise stocks on improving booking momentum
06/16/21 Wolfe Research
Carnival upgraded to Outperform from Peer Perform at Wolfe Research
06/11/21 Credit Suisse
Royal Caribbean selloff on Covid cases an opportunity, says Credit Suisse
06/11/21 Argus
Carnival price target raised to $35 from $33 at Argus
RCL Royal Caribbean
$88.91 /

+2.03 (+2.34%)

06/16/21 Wolfe Research
Royal Caribbean upgraded to Outperform from Peer Perform at Wolfe Research
04/29/21 William Blair
Royal Caribbean March bookings on par with 2019 peak wave, says William Blair
NCLH Norwegian Cruise Line
$31.68 /

+0.83 (+2.69%)

06/16/21 Wolfe Research
Norwegian Cruise upgraded to Outperform from Peer Perform at Wolfe Research
06/09/21 Stifel
Norwegian Cruise Line price target raised to $40 from $37 at Stifel
BNTX BioNTech
$203.67 /

-14.31 (-6.56%)

06/16/21
Fly Intel: Top five analyst downgrades
06/16/21 Redburn
BioNTech downgraded to Sell from Neutral at Redburn
05/18/21
Fly Intel: Top five analyst initiations
05/18/21 Goldman Sachs
BioNTech initiated with a Neutral at Goldman Sachs
MAXR Maxar Technologies
$41.55 /

+5.55 (+15.42%)

06/16/21
Fly Intel: Top five analyst initiations
06/16/21 Goldman Sachs
Maxar Technologies initiated with a Buy at Goldman Sachs
05/04/21 JPMorgan
Maxar Technologies positive outlook intact despite miss, says JPMorgan
04/05/21 TD Securities
TD upgrades Maxar Technologies on 'compelling' entry after selloff
WKHS Workhorse Group
$15.43 /

+1.265 (+8.93%)

VIAV Viavi
$17.98 /

+0.52 (+2.98%)

UTHR United Therapeutics
$184.32 /

+5.52 (+3.09%)

TAL TAL Education
$25.17 /

-3.68 (-12.76%)

RUN Sunrun
$48.51 /

+5.34 (+12.37%)

RCL Royal Caribbean
$88.91 /

+2.03 (+2.34%)

RBLX Roblox
$84.38 /

-5.38 (-5.99%)

RAPT Rapt Therapeutics
$32.84 /

-2.12 (-6.06%)

OSK Oshkosh
$126.18 /

-1.16 (-0.91%)

ORCL Oracle
$77.07 /

-4.57 (-5.60%)

NUE Nucor
$100.95 /

-0.96 (-0.94%)

NCLH Norwegian Cruise Line
$31.68 /

+0.83 (+2.69%)

MNKD MannKind
$4.41 /

+0.3 (+7.30%)

MAXR Maxar Technologies
$41.55 /

+5.55 (+15.42%)

LZB La-Z-Boy
$38.10 /

-4.25 (-10.04%)

LUV Southwest
$57.46 /

+0.33 (+0.58%)

KO Coca-Cola
$55.02 /

-0.405 (-0.73%)

KKR KKR
$56.49 /

+0.8 (+1.44%)

KIN Kindred Biosciences
$9.20 /

+2.85 (+44.88%)

GM General Motors
$62.21 /

+1.4 (+2.30%)

FRPT Freshpet
$164.18 /

-0.92 (-0.56%)

F Ford
$15.08 /

+0.08 (+0.53%)

EXFO Exfo
$6.92 /

+0.985 (+16.60%)

ELAN Elanco
$35.95 /

+1.12 (+3.22%)

DISH Dish
$41.66 /

+1.5 (+3.74%)

CVS CVS Health
$85.85 /

+0.44 (+0.52%)

CNC Centene
$74.10 /

+4.09 (+5.84%)

CCL Carnival
$29.36 /

+0.745 (+2.60%)

BNTX BioNTech
$203.67 /

-14.31 (-6.56%)

APO Apollo Global
$58.54 /

+0.54 (+0.93%)

AMZN Amazon.com
$3,398.69 /

+16.67 (+0.49%)

  • 16
    Jun
  • 28
    May
  • 18
    Mar
  • 05
    Mar
  • 01
    Mar
  • 24
    Feb
  • 23
    Feb
  • 01
    Dec
  • 18
    Nov
  • 12
    Nov
  • 11
    Nov
  • 21
    Oct
  • 14
    Oct
  • 13
    Oct
  • 31
    Jul
  • 23
    Jul
  • 17
    Jul
WKHS Workhorse Group
$15.43 /

+1.265 (+8.93%)

RCL Royal Caribbean
$88.91 /

+2.03 (+2.34%)

RBLX Roblox
$84.38 /

-5.38 (-5.99%)

ORCL Oracle
$77.07 /

-4.57 (-5.60%)

NUE Nucor
$100.95 /

-0.96 (-0.94%)

LUV Southwest
$57.46 /

+0.33 (+0.58%)

KO Coca-Cola
$55.02 /

-0.405 (-0.73%)

KKR KKR
$56.49 /

+0.8 (+1.44%)

GM General Motors
$62.21 /

+1.4 (+2.30%)

FRPT Freshpet
$164.18 /

-0.92 (-0.56%)

F Ford
$15.08 /

+0.08 (+0.53%)

ELAN Elanco
$35.95 /

+1.12 (+3.22%)

DISH Dish
$41.66 /

+1.5 (+3.74%)

CVS CVS Health
$85.85 /

+0.44 (+0.52%)

CNC Centene
$74.10 /

+4.09 (+5.84%)

CCL Carnival
$29.36 /

+0.745 (+2.60%)

BNTX BioNTech
$203.67 /

-14.31 (-6.56%)

APO Apollo Global
$58.54 /

+0.54 (+0.93%)

AMZN Amazon.com
$3,398.69 /

+16.67 (+0.49%)

WKHS Workhorse Group
$15.43 /

+1.265 (+8.93%)

VIAV Viavi
$17.98 /

+0.52 (+2.98%)

UTHR United Therapeutics
$184.32 /

+5.52 (+3.09%)

TAL TAL Education
$25.17 /

-3.68 (-12.76%)

RUN Sunrun
$48.51 /

+5.34 (+12.37%)

RCL Royal Caribbean
$88.91 /

+2.03 (+2.34%)

RBLX Roblox
$84.38 /

-5.38 (-5.99%)

RAPT Rapt Therapeutics
$32.84 /

-2.12 (-6.06%)

OSK Oshkosh
$126.18 /

-1.16 (-0.91%)

ORCL Oracle
$77.07 /

-4.57 (-5.60%)

NCLH Norwegian Cruise Line
$31.68 /

+0.83 (+2.69%)

MAXR Maxar Technologies
$41.55 /

+5.55 (+15.42%)

LZB La-Z-Boy
$38.10 /

-4.25 (-10.04%)

LUV Southwest
$57.46 /

+0.33 (+0.58%)

KO Coca-Cola
$55.02 /

-0.405 (-0.73%)

KKR KKR
$56.49 /

+0.8 (+1.44%)

KIN Kindred Biosciences
$9.20 /

+2.85 (+44.88%)

GOED 1847 Goedeker
$3.34 /

+0.27 (+8.79%)

GM General Motors
$62.21 /

+1.4 (+2.30%)

FRPT Freshpet
$164.18 /

-0.92 (-0.56%)

F Ford
$15.08 /

+0.08 (+0.53%)

EXFO Exfo
$6.92 /

+0.985 (+16.60%)

ELAN Elanco
$35.95 /

+1.12 (+3.22%)

DISH Dish
$41.66 /

+1.5 (+3.74%)

CVS CVS Health
$85.85 /

+0.44 (+0.52%)

CNC Centene
$74.10 /

+4.09 (+5.84%)

CCL Carnival
$29.36 /

+0.745 (+2.60%)

BNTX BioNTech
$203.67 /

-14.31 (-6.56%)

APO Apollo Global
$58.54 /

+0.54 (+0.93%)

WKHS Workhorse Group
$15.43 /

+1.265 (+8.93%)

TAL TAL Education
$25.17 /

-3.68 (-12.76%)

RUN Sunrun
$48.51 /

+5.34 (+12.37%)

RCL Royal Caribbean
$88.91 /

+2.03 (+2.34%)

RBLX Roblox
$84.38 /

-5.38 (-5.99%)

RAPT Rapt Therapeutics
$32.84 /

-2.12 (-6.06%)

ORCL Oracle
$77.07 /

-4.57 (-5.60%)

NUE Nucor
$100.95 /

-0.96 (-0.94%)

NCLH Norwegian Cruise Line
$31.68 /

+0.83 (+2.69%)

MNKD MannKind
$4.41 /

+0.3 (+7.30%)

LUV Southwest
$57.46 /

+0.33 (+0.58%)

KO Coca-Cola
$55.02 /

-0.405 (-0.73%)

GM General Motors
$62.21 /

+1.4 (+2.30%)

F Ford
$15.08 /

+0.08 (+0.53%)

DISH Dish
$41.66 /

+1.5 (+3.74%)

CVS CVS Health
$85.85 /

+0.44 (+0.52%)

CNC Centene
$74.10 /

+4.09 (+5.84%)

CCL Carnival
$29.36 /

+0.745 (+2.60%)

BNTX BioNTech
$203.67 /

-14.31 (-6.56%)

APO Apollo Global
$58.54 /

+0.54 (+0.93%)

AMZN Amazon.com
$3,398.69 /

+16.67 (+0.49%)

Syndicate
Rapt Therapeutics 3.79M share Secondary priced at $33.00 » 06:09
06/16/21
06/16
06:09
06/16/21
06:09
RAPT

Rapt Therapeutics

$34.96 /

-4.97 (-12.45%)

The deal priced below…

The deal priced below last closing price of $35.19. JPMorgan, SVB Leerink and Piper Sandler are acting as joint book running managers for the offering.

ShowHide Related Items >><<
RAPT Rapt Therapeutics
$34.96 /

-4.97 (-12.45%)

RAPT Rapt Therapeutics
$34.96 /

-4.97 (-12.45%)

06/14/21 Wells Fargo
Rapt Therapeutics price target raised to $65 from $30 at Wells Fargo
06/14/21 Roth Capital
Rapt Therapeutics price target raised to $72 from $38 at Roth Capital
06/14/21 Cantor Fitzgerald
Cantor ups Rapt target to $71 after 'robust' atopic dermatitis data
06/14/21 Cantor Fitzgerald
Rapt Therapeutics price target raised to $71 from $51 at Cantor Fitzgerald
RAPT Rapt Therapeutics
$34.96 /

-4.97 (-12.45%)

  • 16
    Jun
RAPT Rapt Therapeutics
$34.96 /

-4.97 (-12.45%)

RAPT Rapt Therapeutics
$34.96 /

-4.97 (-12.45%)

On The Fly
Wall Street in Fives - Must Read Lists for Monday » 16:07
06/14/21
06/14
16:07
06/14/21
16:07
RDS.A

Royal Dutch Shell

$41.18 /

+0.765 (+1.89%)

, RDS.B

Royal Dutch Shell

$39.02 /

+0.775 (+2.03%)

, NVAX

Novavax

$208.17 /

-1.43 (-0.68%)

, MRNA

Moderna

$206.41 /

-12.39 (-5.66%)

, RIDE

Lordstown Motors

$9.19 /

-2.215 (-19.43%)

, TSLA

Tesla

$616.40 /

+6.48 (+1.06%)

, WPG

Washington Prime

$3.35 /

-1.49 (-30.79%)

, CMG

Chipotle

$1,391.53 /

+24.24 (+1.77%)

, CRSP

Crispr Therapeutics

$128.44 /

+1.36 (+1.07%)

, OTLY

Oatly Group

$27.53 /

-1.18 (-4.11%)

, CLB

Core Laboratories

$45.25 /

-2.46 (-5.16%)

, AVB

AvalonBay

$213.71 /

-0.78 (-0.36%)

, VIVHY

Vivendi

$35.46 /

+0.39 (+1.11%)

, NGAC

NextGen Acquisition Corp.

$9.98 /

-0.02 (-0.20%)

, GSK

GlaxoSmithKline

$40.41 /

+0.26 (+0.65%)

, WOOF

Petco

$28.21 /

+4.4 (+18.48%)

, RAPT

Rapt Therapeutics

$40.40 /

+21.805 (+117.26%)

, ITOS

iTeos Therapeutics

$27.50 /

+7.5 (+37.50%)

, BTX

Brooklyn ImmunoTherapeutics

$15.16 /

+0.705 (+4.88%)

, ENDP

Endo

$5.63 /

-0.62 (-9.92%)

, FBIO

Fortress Biotech

$3.80 /

-0.69 (-15.37%)

, ATXI

Avenue Therapeutics

$2.95 /

-1.285 (-30.38%)

, MPAA

Motorcar Parts

$24.13 /

+0.89 (+3.83%)

, KLR

Kaleyra

$11.79 /

-0.61 (-4.92%)

, CANO

Cano Health

$14.80 /

+0.075 (+0.51%)

, CODA

Coda Octopus

$9.90 /

+0.75 (+8.20%)

, DUK

Duke Energy

$102.35 /

+0.42 (+0.41%)

, BTC

Bitcoin

$0.00 /

+ (+0.00%)

, BITCOIN

Bitcoin

/

+

, $BTC

Bitcoin

$0.00 /

+ (+0.00%)

Get caught up quickly on…

ShowHide Related Items >><<
WPG Washington Prime
$3.35 /

-1.49 (-30.79%)

WOOF Petco
$28.21 /

+4.4 (+18.48%)

VIVHY Vivendi
$35.46 /

+0.39 (+1.11%)

TSLA Tesla
$616.40 /

+6.48 (+1.06%)

RIDE Lordstown Motors
$9.19 /

-2.215 (-19.43%)

RDS.B Royal Dutch Shell
$39.02 /

+0.775 (+2.03%)

RDS.A Royal Dutch Shell
$41.18 /

+0.765 (+1.89%)

RAPT Rapt Therapeutics
$40.40 /

+21.805 (+117.26%)

NVAX Novavax
$208.17 /

-1.43 (-0.68%)

NGAC NextGen Acquisition Corp.
$9.98 /

-0.02 (-0.20%)

MRNA Moderna
$206.41 /

-12.39 (-5.66%)

MPAA Motorcar Parts
$24.13 /

+0.89 (+3.83%)

KLR Kaleyra
$11.79 /

-0.61 (-4.92%)

ITOS iTeos Therapeutics
$27.50 /

+7.5 (+37.50%)

GSK GlaxoSmithKline
$40.41 /

+0.26 (+0.65%)

FBIO Fortress Biotech
$3.80 /

-0.69 (-15.37%)

ENDP Endo
$5.63 /

-0.62 (-9.92%)

DUK Duke Energy
$102.35 /

+0.42 (+0.41%)

CRSP Crispr Therapeutics
$128.44 /

+1.36 (+1.07%)

CMG Chipotle
$1,391.53 /

+24.24 (+1.77%)

CLB Core Laboratories
$45.25 /

-2.46 (-5.16%)

CANO Cano Health
$14.80 /

+0.075 (+0.51%)

BTX Brooklyn ImmunoTherapeutics
$15.16 /

+0.705 (+4.88%)

BTC Bitcoin
$0.00 /

+ (+0.00%)

BITCOIN Bitcoin
/

+

AVB AvalonBay
$213.71 /

-0.78 (-0.36%)

ATXI Avenue Therapeutics
$2.95 /

-1.285 (-30.38%)

RDS.A Royal Dutch Shell
$41.18 /

+0.765 (+1.89%)

06/08/21 DZ Bank
Royal Dutch Shell downgraded to Hold from Buy at DZ Bank
05/17/21 Mizuho
Royal Dutch Shell price target raised to $61 from $56 at Mizuho
04/30/21 Credit Suisse
Royal Dutch Shell price target raised to 1,860 GBp at Credit Suisse
04/20/21 Deutsche Bank
Royal Dutch Shell initiated with a Buy at Deutsche Bank
RDS.B Royal Dutch Shell
$39.02 /

+0.775 (+2.03%)

04/08/21 Barclays
Royal Dutch Shell price target raised to 1,700 GBp from 1,500 GBp at Barclays
03/12/21 Societe Generale
Royal Dutch Shell upgraded to Buy from Hold at Societe Generale
03/03/21 JPMorgan
Royal Dutch Shell price target raised to 2,000 GBp from 1,700 GBp at JPMorgan
02/12/21 Scotiabank
Royal Dutch Shell upgraded to Sector Perform from Underperform at Scotiabank
NVAX Novavax
$208.17 /

-1.43 (-0.68%)

06/07/21 B. Riley
Novavax risk/reward attractive into Covid vaccine data, says B. Riley
05/12/21
Fly Intel: Top five analyst downgrades
05/12/21 B. Riley
Novavax price target lowered to $286 from $365 at B. Riley
05/12/21 Cantor Fitzgerald
Novavax price target lowered to $217 from $338 at Cantor Fitzgerald
MRNA Moderna
$206.41 /

-12.39 (-5.66%)

06/10/21 Piper Sandler
Moderna should be vaccinating teens this summer, says Piper Sandler
06/07/21 Piper Sandler
Moderna price target raised to $246 from $231 at Piper Sandler
05/21/21 Piper Sandler
Piper says overseas approvals providing 'second leg of growth' for Moderna
05/07/21 Barclays
Moderna price target raised to $194 from $178 at Barclays
RIDE Lordstown Motors
$9.19 /

-2.215 (-19.43%)

06/14/21 Morgan Stanley
Lordstown management change 'important first step,' says Morgan Stanley
06/14/21 R.F. Lafferty
R.F. Lafferty downgrades Lordstown to Sell with $3 target on uncertainty
06/14/21 R.F. Lafferty
Lordstown Motors downgraded to Sell from Hold at R.F. Lafferty
06/10/21 Morgan Stanley
Morgan Stanley removes Lordstown rating, says market may be underestimating risk
TSLA Tesla
$616.40 /

+6.48 (+1.06%)

06/14/21 Canaccord
Tesla price target lowered to $812 from $974 at Canaccord
06/11/21 Credit Suisse
Tesla's Model S Plaid reinforces brand DNA, says Credit Suisse
06/11/21 Goldman Sachs
Goldman says Tesla's Model S Plaid helps illustrate technology leadership
06/08/21 GLJ Research
Tesla's China orders down 69% in Q2 versus Q1, says GLJ Research
WPG Washington Prime
$3.35 /

-1.49 (-30.79%)

04/06/21 Truist
Washington Prime upgraded to Hold from Sell at Truist
04/05/21 Truist
Washington Prime upgraded to Hold from Sell at Truist
02/16/21 Truist
Washington Prime coupon non-payment part of negotiating process, says Truist
02/01/21 Truist
Macerich Q4 results 'weak,' but not much worse than expected, says Truist
CMG Chipotle
$1,391.53 /

+24.24 (+1.77%)

06/14/21
Fly Intel: Top five analyst upgrades
06/14/21 Wells Fargo
Chipotle price target lowered to $1,720 from $1,818 at Wells Fargo
06/14/21 Raymond James
Raymond James upgrades Chipotle to Strong Buy on menu price hikes
06/14/21 Raymond James
Chipotle upgraded to Strong Buy from Outperform at Raymond James
CRSP Crispr Therapeutics
$128.44 /

+1.36 (+1.07%)

06/14/21 Citi
Crispr Therapeutics upgraded to Neutral from Sell at Citi
06/11/21 Roth Capital
Crispr Therapeutics reported 'robust' sickle cell data, says Roth Capital
05/13/21 Evercore ISI
Crispr Therapeutics upgraded to Outperform from In Line at Evercore ISI
OTLY Oatly Group
$27.53 /

-1.18 (-4.11%)

06/14/21
Fly Intel: Top five analyst initiations
06/14/21 Jefferies
Oatly Group initiated with a Buy at Jefferies
06/14/21 JPMorgan
Oatly Group initiated with a Neutral at JPMorgan
06/14/21 Truist
Oatly Group initiated with a Buy at Truist
CLB Core Laboratories
$45.25 /

-2.46 (-5.16%)

06/14/21
Fly Intel: Top five analyst downgrades
06/14/21 Citi
Core Laboratories downgraded to Sell from Neutral at Citi
04/23/21 Citi
Core Laboratories price target lowered to $30 from $36 at Citi
01/11/21 Wolfe Research
Core Laboratories upgraded to Peer Perform from Underperform at Wolfe Research
AVB AvalonBay
$213.71 /

-0.78 (-0.36%)

06/14/21 Evercore ISI
AvalonBay downgraded to In Line from Outperform at Evercore ISI
06/11/21 Morgan Stanley
AvalonBay price target raised to $218 from $210 at Morgan Stanley
06/04/21 Truist
AvalonBay downgraded to Hold from Buy at Truist on premium valuation
VIVHY Vivendi
$35.46 /

+0.39 (+1.11%)

06/01/21
Fly Intel: Top five analyst downgrades
06/01/21 Bernstein
Vivendi downgraded to Market Perform from Outperform at Bernstein
05/14/21 Credit Suisse
Vivendi price target lowered to EUR 32.20 from EUR 32.40 at Credit Suisse
04/23/21 Barclays
Vivendi price target raised to EUR 32 from EUR 31 at Barclays
NGAC NextGen Acquisition Corp.
$9.98 /

-0.02 (-0.20%)

06/11/21 Benchmark
NextGen Acquisition Corp. initiated with a Buy at Benchmark
GSK GlaxoSmithKline
$40.41 /

+0.26 (+0.65%)

06/14/21 Piper Sandler
iTeos deal 'addresses a number of needs all at once, says Piper Sandler
06/11/21 Deutsche Bank
GlaxoSmithKline price target raised to 1,300 GBp at Deutsche Bank
05/27/21 Piper Sandler
Xencorc royalty revenue streams growing, says Piper Sandler
05/11/21 UBS
GlaxoSmithKline price target raised to 1,370 GBp from 1,360 GBp at UBS
WOOF Petco
$28.21 /

+4.4 (+18.48%)

06/02/21
Fly Intel: Top five analyst initiations
06/02/21 Citi
Petco reinstated with a Buy at Citi
05/21/21 Baird
Petco weakness a buying opportunity, says at Baird
05/20/21 Baird
Petco pullback a buying opportunity, says Baird
RAPT Rapt Therapeutics
$40.40 /

+21.805 (+117.26%)

06/14/21 Wells Fargo
Rapt Therapeutics price target raised to $65 from $30 at Wells Fargo
06/14/21 Roth Capital
Rapt Therapeutics price target raised to $72 from $38 at Roth Capital
06/14/21 Cantor Fitzgerald
Cantor ups Rapt target to $71 after 'robust' atopic dermatitis data
06/14/21 Cantor Fitzgerald
Rapt Therapeutics price target raised to $71 from $51 at Cantor Fitzgerald
ITOS iTeos Therapeutics
$27.50 /

+7.5 (+37.50%)

05/19/21 SVB Leerink
iTeos Therapeutics price target lowered to $45 from $60 at SVB Leerink
05/14/21 Piper Sandler
iTeos Therapeutics recent pullback unwarranted, says Piper Sandler
05/05/21 H.C. Wainwright
iTeos Therapeutics initiated with a Buy at H.C. Wainwright
BTX Brooklyn ImmunoTherapeutics
$15.16 /

+0.705 (+4.88%)

ENDP Endo
$5.63 /

-0.62 (-9.92%)

05/17/21 Citi
Endo price target raised to $11 from $10 at Citi
04/06/21 RBC Capital
Endo transferred with a Sector Perform at RBC Capital
03/08/21 Barclays
Endo price target raised to $7 from $6 at Barclays
03/04/21 Citi
Endo price target lowered to $10 from $11 at Citi
FBIO Fortress Biotech
$3.80 /

-0.69 (-15.37%)

04/14/21 B. Riley
Fortress Biotech weakness yesterday a buying opportunity, says B. Riley
04/05/21 B. Riley
Fortress Biotech price target raised to $9 from $8 at B. Riley
02/17/21 Dawson James
Fortress Biotech price target raised to $21 from $16 at Dawson James
12/14/20 Benchmark
Decision looms on Fortress' Caelum after partner Alexion bought, says Benchmark
ATXI Avenue Therapeutics
$2.95 /

-1.285 (-30.38%)

03/01/21 H.C. Wainwright
InvaGen takeout 'may still be in play' at Avenue, says H.C. Wainwright
10/12/20 H.C. Wainwright
Avenue downgraded to Neutral on merger uncertainty at H.C. Wainwright
MPAA Motorcar Parts
$24.13 /

+0.89 (+3.83%)

02/04/21 B. Riley
Motorcar Parts price target raised to $28 from $25 at B. Riley Securities
08/11/20 Craig-Hallum
Motorcar Parts downgraded to Hold from Buy at Craig-Hallum
07/01/20 B. Riley
Motorcar Parts transferred with Buy rating at B. Riley FBR
06/19/20 Roth Capital
Motorcar Parts assumed with a Buy at Roth Capital
KLR Kaleyra
$11.79 /

-0.61 (-4.92%)

06/11/21 Northland
Kaleyra price target raised to $29 from $23 at Northland
03/19/21 Northland
Kaleyra on track for 21% growth in Q1, says Northland
02/22/21 Maxim
Kaleyra price target raised to $42 from $30 at Maxim
02/17/21 Craig-Hallum
Kaleyra price target raised to $25 from $20 at Craig-Hallum
CANO Cano Health
$14.80 /

+0.075 (+0.51%)

11/19/20 Compass Point
Compass Point upgrades PennantPark to Buy after Cano Health 'game changer'
CODA Coda Octopus
$9.90 /

+0.75 (+8.20%)

06/14/21 Alliance Global Partners
Coda Octopus price target raised to $13 from $11 at Alliance Global
DUK Duke Energy
$102.35 /

+0.42 (+0.41%)

05/18/21 Morgan Stanley
Morgan Stanley sees 'low probability' Duke Energy and Elliott reach agreement
05/12/21 Mizuho
Duke Energy price target raised to $105 from $96 at Mizuho
04/14/21 Credit Suisse
Duke Energy price target raised to $104 from $96 at Credit Suisse
04/14/21 Wells Fargo
Duke Energy price target raised to $104 from $97 at Wells Fargo
BTC Bitcoin
$0.00 /

+ (+0.00%)

04/27/21 Roth Capital
Regulatory credits, bitcoin fuel Tesla Q1 headline beat, says Roth Capital
04/15/21 Morgan Stanley
WisdomTree Bitcoin ETP cross-listing could speed up growth, says Morgan Stanley
01/13/21 Standpoint Research
Bitcoin could hit $112,000 this year, says Standpoint Research
BITCOIN Bitcoin
/

+

05/13/21 BTIG
BTIG sees Binance news as 'net positive' for Coinbase
$BTC Bitcoin
$0.00 /

+ (+0.00%)

WPG Washington Prime
$3.35 /

-1.49 (-30.79%)

WOOF Petco
$28.21 /

+4.4 (+18.48%)

TSLA Tesla
$616.40 /

+6.48 (+1.06%)

RIDE Lordstown Motors
$9.19 /

-2.215 (-19.43%)

RDS.A Royal Dutch Shell
$41.18 /

+0.765 (+1.89%)

RAPT Rapt Therapeutics
$40.40 /

+21.805 (+117.26%)

NVAX Novavax
$208.17 /

-1.43 (-0.68%)

MRNA Moderna
$206.41 /

-12.39 (-5.66%)

MPAA Motorcar Parts
$24.13 /

+0.89 (+3.83%)

KLR Kaleyra
$11.79 /

-0.61 (-4.92%)

ITOS iTeos Therapeutics
$27.50 /

+7.5 (+37.50%)

GSK GlaxoSmithKline
$40.41 /

+0.26 (+0.65%)

FBIO Fortress Biotech
$3.80 /

-0.69 (-15.37%)

ENDP Endo
$5.63 /

-0.62 (-9.92%)

DUK Duke Energy
$102.35 /

+0.42 (+0.41%)

CRSP Crispr Therapeutics
$128.44 /

+1.36 (+1.07%)

CODA Coda Octopus
$9.90 /

+0.75 (+8.20%)

CMG Chipotle
$1,391.53 /

+24.24 (+1.77%)

CLB Core Laboratories
$45.25 /

-2.46 (-5.16%)

CANO Cano Health
$14.80 /

+0.075 (+0.51%)

BTC Bitcoin
$0.00 /

+ (+0.00%)

AVB AvalonBay
$213.71 /

-0.78 (-0.36%)

  • 27
    May
  • 20
    May
  • 14
    Jan
  • 24
    Jul
  • 01
    Jul
  • 25
    Jun
WPG Washington Prime
$3.35 /

-1.49 (-30.79%)

WOOF Petco
$28.21 /

+4.4 (+18.48%)

VIVHY Vivendi
$35.46 /

+0.39 (+1.11%)

TSLA Tesla
$616.40 /

+6.48 (+1.06%)

RIDE Lordstown Motors
$9.19 /

-2.215 (-19.43%)

RDS.B Royal Dutch Shell
$39.02 /

+0.775 (+2.03%)

RDS.A Royal Dutch Shell
$41.18 /

+0.765 (+1.89%)

OTLY Oatly Group
$27.53 /

-1.18 (-4.11%)

NVAX Novavax
$208.17 /

-1.43 (-0.68%)

NGAC NextGen Acquisition Corp.
$9.98 /

-0.02 (-0.20%)

MRNA Moderna
$206.41 /

-12.39 (-5.66%)

GSK GlaxoSmithKline
$40.41 /

+0.26 (+0.65%)

ENDP Endo
$5.63 /

-0.62 (-9.92%)

DUK Duke Energy
$102.35 /

+0.42 (+0.41%)

CMG Chipotle
$1,391.53 /

+24.24 (+1.77%)

BTC Bitcoin
$0.00 /

+ (+0.00%)

WOOF Petco
$28.21 /

+4.4 (+18.48%)

VIVHY Vivendi
$35.46 /

+0.39 (+1.11%)

TSLA Tesla
$616.40 /

+6.48 (+1.06%)

RIDE Lordstown Motors
$9.19 /

-2.215 (-19.43%)

RDS.B Royal Dutch Shell
$39.02 /

+0.775 (+2.03%)

RDS.A Royal Dutch Shell
$41.18 /

+0.765 (+1.89%)

OTLY Oatly Group
$27.53 /

-1.18 (-4.11%)

NVAX Novavax
$208.17 /

-1.43 (-0.68%)

NGAC NextGen Acquisition Corp.
$9.98 /

-0.02 (-0.20%)

MRNA Moderna
$206.41 /

-12.39 (-5.66%)

KLR Kaleyra
$11.79 /

-0.61 (-4.92%)

GSK GlaxoSmithKline
$40.41 /

+0.26 (+0.65%)

FBIO Fortress Biotech
$3.80 /

-0.69 (-15.37%)

ENDP Endo
$5.63 /

-0.62 (-9.92%)

DUK Duke Energy
$102.35 /

+0.42 (+0.41%)

CRSP Crispr Therapeutics
$128.44 /

+1.36 (+1.07%)

CMG Chipotle
$1,391.53 /

+24.24 (+1.77%)

CLB Core Laboratories
$45.25 /

-2.46 (-5.16%)

BTX Brooklyn ImmunoTherapeutics
$15.16 /

+0.705 (+4.88%)

BTC Bitcoin
$0.00 /

+ (+0.00%)

ATXI Avenue Therapeutics
$2.95 /

-1.285 (-30.38%)

WPG Washington Prime
$3.35 /

-1.49 (-30.79%)

WOOF Petco
$28.21 /

+4.4 (+18.48%)

TSLA Tesla
$616.40 /

+6.48 (+1.06%)

RIDE Lordstown Motors
$9.19 /

-2.215 (-19.43%)

OTLY Oatly Group
$27.53 /

-1.18 (-4.11%)

NVAX Novavax
$208.17 /

-1.43 (-0.68%)

NGAC NextGen Acquisition Corp.
$9.98 /

-0.02 (-0.20%)

MRNA Moderna
$206.41 /

-12.39 (-5.66%)

KLR Kaleyra
$11.79 /

-0.61 (-4.92%)

GSK GlaxoSmithKline
$40.41 /

+0.26 (+0.65%)

FBIO Fortress Biotech
$3.80 /

-0.69 (-15.37%)

ENDP Endo
$5.63 /

-0.62 (-9.92%)

CRSP Crispr Therapeutics
$128.44 /

+1.36 (+1.07%)

CMG Chipotle
$1,391.53 /

+24.24 (+1.77%)

CANO Cano Health
$14.80 /

+0.075 (+0.51%)

BTX Brooklyn ImmunoTherapeutics
$15.16 /

+0.705 (+4.88%)

Syndicate
Rapt Therapeutics offers to sell $125M in common stock » 16:02
06/14/21
06/14
16:02
06/14/21
16:02
RAPT

Rapt Therapeutics

$40.32 /

+21.725 (+116.83%)

J.P. Morgan, SVB Leerink…

J.P. Morgan, SVB Leerink and Piper Sandler are acting as joint lead book-running managers for the proposed offering. Cantor is acting as book-running manager for the proposed offering.

ShowHide Related Items >><<
RAPT Rapt Therapeutics
$40.32 /

+21.725 (+116.83%)

RAPT Rapt Therapeutics
$40.32 /

+21.725 (+116.83%)

06/14/21 Wells Fargo
Rapt Therapeutics price target raised to $65 from $30 at Wells Fargo
06/14/21 Roth Capital
Rapt Therapeutics price target raised to $72 from $38 at Roth Capital
06/14/21 Cantor Fitzgerald
Cantor ups Rapt target to $71 after 'robust' atopic dermatitis data
06/14/21 Cantor Fitzgerald
Rapt Therapeutics price target raised to $71 from $51 at Cantor Fitzgerald
RAPT Rapt Therapeutics
$40.32 /

+21.725 (+116.83%)

RAPT Rapt Therapeutics
$40.32 /

+21.725 (+116.83%)

RAPT Rapt Therapeutics
$40.32 /

+21.725 (+116.83%)

Recommendations
Rapt Therapeutics price target raised to $65 from $30 at Wells Fargo » 14:23
06/14/21
06/14
14:23
06/14/21
14:23
RAPT

Rapt Therapeutics

$40.15 /

+21.555 (+115.92%)

Wells Fargo analyst Yanan…

Wells Fargo analyst Yanan Zhu raised the firm's price target on Rapt Therapeutics to $65 from $30 and keeps an Overweight rating on the shares following the top-line Phase 1b results for RPT193 in atopic dermatitis. RPT193 has demonstrated clear proof-of-concept, with initial data supporting its profile as a safe, oral alternative to Dupixent, Zhu tells investors in a research note. The analyst says the favorable safety profile of RPT193 should support differentiation from oral JAK inhibitors. Zhu raised RPT193's probability of success to 50% from 20%.

ShowHide Related Items >><<
RAPT Rapt Therapeutics
$40.15 /

+21.555 (+115.92%)

RAPT Rapt Therapeutics
$40.15 /

+21.555 (+115.92%)

06/14/21 Roth Capital
Rapt Therapeutics price target raised to $72 from $38 at Roth Capital
06/14/21 Cantor Fitzgerald
Cantor ups Rapt target to $71 after 'robust' atopic dermatitis data
06/14/21 Cantor Fitzgerald
Rapt Therapeutics price target raised to $71 from $51 at Cantor Fitzgerald
05/17/21 H.C. Wainwright
Rapt Therapeutics price target lowered to $29 from $32 at H.C. Wainwright
RAPT Rapt Therapeutics
$40.15 /

+21.555 (+115.92%)

RAPT Rapt Therapeutics
$40.15 /

+21.555 (+115.92%)

RAPT Rapt Therapeutics
$40.15 /

+21.555 (+115.92%)

Recommendations
Rapt Therapeutics price target raised to $72 from $38 at Roth Capital » 13:45
06/14/21
06/14
13:45
06/14/21
13:45
RAPT

Rapt Therapeutics

$37.17 /

+18.575 (+99.89%)

Roth Capital analyst…

Roth Capital analyst Zegbeh Jallah raised the firm's price target on Rapt Therapeutics to $72 from $38 and keeps a Buy rating on the shares after the company presented positive topline data from its Phase 1b study of RPT193 in moderate-to-severe Atopic Dermatitis patients. Of patients receiving a once-daily oral dose of RPT193, 43% and 62% achieved EASI50 at weeks 4 and 6, respectively versus Placebo, and all AEs were mild-to-moderate, the analyst notes. With efficacy and safety that seems competitive to the subcutaneously-delivered blockbuster, DUPIXENT, Jallah contends.

ShowHide Related Items >><<
RAPT Rapt Therapeutics
$37.17 /

+18.575 (+99.89%)

RAPT Rapt Therapeutics
$37.17 /

+18.575 (+99.89%)

06/14/21 Cantor Fitzgerald
Cantor ups Rapt target to $71 after 'robust' atopic dermatitis data
06/14/21 Cantor Fitzgerald
Rapt Therapeutics price target raised to $71 from $51 at Cantor Fitzgerald
05/17/21 H.C. Wainwright
Rapt Therapeutics price target lowered to $29 from $32 at H.C. Wainwright
04/12/21 Roth Capital
Roth says Rapt Therapeutics' AACR presentations highlight broad potential
RAPT Rapt Therapeutics
$37.17 /

+18.575 (+99.89%)

RAPT Rapt Therapeutics
$37.17 /

+18.575 (+99.89%)

RAPT Rapt Therapeutics
$37.17 /

+18.575 (+99.89%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.